| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |